CEBP alpha Recombinant Antibody

$25 ug total protein per lane of various lysates (see on figure) probed with CEBP alpha monoclonal antibody, unconjugated (bsm-61291R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.$

25 ug total protein per lane of various lysates (see on figure) probed with CEBP alpha monoclonal antibody, unconjugated (bsm-61291R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.

Applications

WB
IP
Flow-Cyt

Reactivity

Human

Predicted Reactivity

Mouse
Rat

Overview
Catalog #	bsm-61291r
Product Name	CEBP alpha Recombinant Antibody
Applications	WB, IP, Flow-Cyt
Reactivity	Human
Predicted Reactivity	Mouse, Rat
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from human CEBP alpha
Clonality	Recombinant
Isotype	IgG
Concentration	Lot dependent
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Storage Condition	Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	1050
Swiss Prot	P49715
Subcellular location	Nucleus
Synonyms	C/EBP alpha; CCAAT/enhancer binding protein alpha; CEBPA.
Background	Transcription factor that coordinates proliferation arrest and the differentiation of myeloid progenitors, adipocytes, hepatocytes, and cells of the lung and the placenta. Binds directly to the consensus DNA sequence 5'-T[TG]NNGNAA[TG]-3' acting as an activator on distinct target genes.During early embryogenesis, plays essential and redundant functions with CEBPB. Essential for the transition from common myeloid progenitors (CMP) to granulocyte/monocyte progenitors (GMP). Critical for the proper development of the liver and the lung.
Application Dilution
WB	1:300-5000
IP	1-2ug
Flow-Cyt	1ug/Test